(Q34124333)

English

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Papanastassiou V

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Rampling R

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Fraser M

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Petty R

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hadley D

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nicoll J

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Harland J

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mabbs R

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Brown M

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

398-406

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Treatment of Experimental Intracranial Murine Melanoma with a Neuroattenuated Herpes Simplex Virus 1 Mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Histopathological responses in the CNS following inoculation with a non-neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): relevance for gene and cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Intralesional injection of herpes simplex virus 1716 in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

A cultured human oligodendroglioma cell line and herpes simplex virus-infected cells share antigenic determinants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Establishment of PCR for the early diagnosis of herpes simplex encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

21 January 2018

Therapy of a murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response to herpes simplex virus infections: virus-specific antibodies in sera from patients with recurrent facial infections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301664

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301664

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34124333&oldid=2196281336"